Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Addictions
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Addictions
    Buprenorphine Effective in Treatment of Heroin Dependency - (DGNews)
    TopAbstracts in Addictions 06/26/2008 - (DGNews)
    TopAbstracts in Addictions 06/12/2008 - (DGNews)
    Topiramate Reduces Heavy Drinking and Symptoms of Alcoholism - (DGNews)
    Clusters of Genetic Variants Linked to Distinct Treatment Responses for Smoking Cessation - (DGNews)

    News archive

     Recent webcasts/CME - Addictions
      Balanced Opioid Prescribing
      Opioid Addiction: No Reason to Withhold Pain Management
      Drugs of Abuse: A Pharmacist's Guide
      Achieving Treatment Success in Alcohol Dependence: Integrating Pharmacologic and Psychosocial Approaches
      ADHD and Co-Occurring Substance Use Disorders: New Clinical Insights and Emerging Therapies

      Webcasts/CME archive

       Recent cases - Addictions
        Decrease in Tobacco Consumption After Treatment with Topiramate and Aripiprazole
        Calcific Myofibrosis Due to Pentazocine Abuse: A Case Report
        A Novel SPINK1 Gene Mutation, c.206C>T, in a Thai Patient with Chronic Alcoholic Pancreatitis
        Community-Acquired Klebsiella Pneumoniae Meningitis in an Alcoholic Patient with an Infected Pancreatic Pseudocyst: A Case Report and Review of the Literature
        Coal Tar Creosote Abuse by Vapour Inhalation Presenting with Renal Impairment and Neurotoxicity: A Case Report

        Cases archive
          




        my personal edition > addictions > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Naltrexone Reduces Craving in Alcohol Dependence

        A DGReview of :"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis"
        Psychopharmacology

        02/28/2002
        By David Ball


        People who are alcohol dependent can reduce both the desire to drink and the amount consumed by taking the opioid antagonist naltrexone, United States researchers suggest.

        Naltrexone may suppress the craving for alcohol, in part, by activating the hypothalamo-pituitary-adrenocortical axis.

        The researchers, from Yale University in Connecticut and Rockefeller University in New York, designed the study to determine how naltrexone reduces the risk of relapsing into heavy drinking in alcohol dependent individuals. Eighteen non-treatment-seeking, alcohol-dependent volunteers were randomized to receive either placebo or 50 mg of naltrexone over a six day period. On the sixth day, after baseline assessments of craving and endocrine levels, they were given a priming drink designed to raise blood alcohol levels to 0.03 g/dl. Over the next two hours, the subjects were offered up to eight additional drinks, each designed to raise blood alcohol levels by 0.015 g/dl, or the opportunity to receive US $3 for each drink not consumed.

        At baseline, subjects in the naltrexone group had higher cortisol levels and lower levels of craving than did the placebo subjects.While no significant differences were seen in responses to the priming dose, subjects on naltrexone drank fewer drinks and consumed them more slowly. They also reported lower levels of craving throughout the alcohol self-administration.

        Higher levels of adrenocorticotropic hormone and cortisol were found in naltrexone than in placebo subjects and levels of cortisol were negatively correlated with intensity of the craving for alcohol. Positive correlations were found with the number of drinks chosen and level of alcohol craving.

        There was no difference between the two groups on ratings of nausea, which were low, at any point in the study.
        Psychopharmacology 2002, 160: 19-29. "Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send